Skip to main content
Equibles

Tower Research Capital LLC (TRC)

Position in IMDX — Insight Molecular Diagnostics Inc.

CIK 1533421 NEW YORK, NY
Back to IMDX Full portfolio

Position in IMDX

as of Jun 30, 2026 · filed Aug 11, 2026
Position Value
$15,876
+$14,001 QoQ
Shares Held
2,691
+976.4% QoQ
Ownership
0.008%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#28
of 40 holders
Holding Since
Sep 2023
11 quarters on record
Voting authority Sole 100% Shared 0% None 0%

Common Shares in IMDX Over Time

Shares Held

Position Value (USD)

Position in Diagnostics & Research

Healthcare · as of Jun 30, 2026

Tower Research Capital LLC (TRC) holds $17,636,052 across 41 Diagnostics & Research names. IMDX ranks #31 (0.1% of the industry book) .

# Ticker Company Shares Value (USD) Open
1 GH
Guardant Health, Inc.
 22,531 $3,380,325
2 TMO
Thermo Fisher Scientific Inc.
 5,984 $3,000,137
3 ILMN
Illumina, Inc.
 12,857 $2,260,646
4 DHR
Danaher Corp /De/
 11,068 $2,108,232
5 MEDP
Medpace Holdings, Inc.
 1,661 $879,648
6 IDXX
Idexx Laboratories Inc /De
 1,401 $737,542
7 RVTY
Revvity, Inc.
 5,871 $653,206
8 A
Agilent Technologies, Inc.
 4,814 $639,443

All Filings in IMDX

Export CSV
11 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $15,876 2,691
2025-12-31 $1,875 250
2025-09-30 $2,071 624
2025-06-30 $13,493 4,468
2025-03-31 $3,561 1,164
2024-12-31 $10,264 4,313
2024-09-30 $4,121 1,446
2024-06-30 $9,053 3,069
2024-03-31 $5,508 1,880
2023-12-31 $8,324 3,330
2023-09-30 $7,973 2,556